North America Pharmaceutical Gelatin Market Size, Share & Industry Trends Analysis Report By Type (Type B and Type A), By Source (Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry), By Function, By Application, By Country and Growth Forecast, 2022 - 2028
The North America Pharmaceutical Gelatin Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
As a binder used in tablets, gelatin can be divided into two non-gelling and gelling. Gelling gelation is made of use post granulation of the powder in compression. It has the ability to resist and provide higher gel strength along with providing hardness to the tablets. The high gel strength indicates that the disintegration rate is longer. For direct compression, non-gelling gelatin is used. A fast disintegration rate of non-gelling gelatin enables the medicine to impact the patient faster.
An essential component of plasma substitutes is hydrolyzed gelatin. A Plasma substitute is a class of parenteral formulation that is called a volume expander. When hydrolyzed, gelatin is highly purified with short levels of endotoxin, it can be utilized in medical emergencies for the expansion of blood temporarily.
Exceptional modifications are required for the hydrolyzed gelatin to be used. Plasma substitutes use mainly two types of modified gelatin succinylated gelatin and urea-linked gelatin. Succinylated gelatin is a commonly used one. It possesses improved body compatibility. Urea-linked gelatin gets modified by cross-linking polypeptides. The diffusion rate is slow in this kind of gelatin. It is used as a stabilizer in several vaccines due to the presence of low endotoxin levels.
The United States is still the most significant foreign supplier of pharmaceutical products to the Mexican market. In 2021, the United States exported around USD 870 million to Mexico, accounting for 17% of the total import market share. Hence, the rising import & exports of medicines, combined with the robust market for drugs, is expected to propel the usage of the pharmaceutical gelatin market in the region, thus supporting the market growth.
The US market dominated the North America Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $371.3 million by 2028. The Canada market is experiencing a CAGR of 6.7% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 6.1% during (2022 - 2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Scope of the Study
Market Segments covered in the Report:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook